All News Eterna Therapeutics Inc.

Equities

ERNA

US1140822099

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-24 pm EDT			5-day change	1st Jan Change
1.74 ^USD	-11.22%		-19.07%	-3.06%

Mar. 15	North American Morning Briefing : Inflation -2-	DJ
Mar. 14	Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Inflation -2-	Mar. 15	DJ
Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors	Feb. 20	AQ
Eterna Therapeutics Inc. Announces Appointment of Peter Cicala, JD to Its Board of Directors	Feb. 20	CI
Eterna Therapeutics Inc. Announces Appointment of Peter Cicala to the Board of the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee	Feb. 16	CI
Eterna Therapeutics Inc. Announces Management Changes	Jan. 19	CI
Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)	Jan. 03	AQ
Eterna Therapeutics Inc Announces Chief Executive Officer Changes, Effective January 1, 2024	Dec. 20	CI
Eterna Therapeutics Inc Appoints Sanjeev Luther as President and Member of the Board of Directors, Effective January 1, 2024	Dec. 20	CI
Eterna Therapeutics Inc. Appoints James Bristol as Chairman of the Board	Dec. 20	CI
Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer	Dec. 20	AQ
Eterna Therapeutics Selling $9.2 Million of Convertible Promissory Notes, Accompanying Warrants	Dec. 15	MT
Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing	Dec. 14	AQ
Eterna Therapeutics Inc. announced that it expects to receive $9.2 million in funding	Dec. 13	CI
Eterna Therapeutics Inc. announced that it has received $1.5 million in funding	Dec. 07	CI
Eterna Therapeutics Inc. Enter into an Exclusive Amended and Restated License Agreement with Factor Bioscience Limited	Nov. 16	CI
Eterna Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Eterna Therapeutics Inc. Appoints James Bristol to Its Board of Directors	Nov. 01	CI
Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors	Nov. 01	AQ
Calidi Biotherapeutics Names Andrew Jackson as Chief Financial Officer	23-10-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Eterna Therapeutics Inc.

Equities

ERNA

US1140822099

All News

Filters